Risk of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patient Treated With Natalizumab: A Systematic Review.

Curēus
Govinathan VivekanandanSafeera Khan

Abstract

Natalizumab, a monoclonal antibody acting on alpha4 integrin receptors, is frequently used to treat multiple sclerosis patients. The biggest downside is the risk of development of progressive multifocal leukoencephalopathy, an immune-related condition affecting mainly the central nervous system. The presence of the John Cunningham virus (JCV) and its reactivation is an important factor in the development of progressive multifocal leukoencephalopathy (PML). This study highlights its different proposed mechanism and risk factors strongly related to natalizumab-induced progressive multifocal leukoencephalopathy. The pieces of literature will also be reviewed to look for a relation between the JCV and natalizumab-induced progressive multifocal leukoencephalopathy in multiple sclerosis treated patients. The articles were searched from three databases and reviewed systematically. The inclusion criteria for this study were patients aged 20-50 years, English language paper, full-text availability, and human studies, whereas articles on patients with AIDS and cancer-related disease prior to natalizumab treatment were excluded. Out of 6531 articles identified after applying the search strategy on three main databases PubMed, Google Schol...Continue Reading

References

Nov 18, 1965·Acta Neuropathologica·L Silverman, L J Rubinstein
Oct 14, 2006·Annals of the Rheumatic Diseases·J R Berger
Apr 19, 2011·Current Opinion in Neurology·Tory Johnson, Avindra Nath
Jan 1, 2009·ClinicoEconomics and Outcomes Research : CEOR·Francesco Patti, Angelo Pappalardo
Jun 20, 2012·Journal of Neuropathology and Experimental Neurology·B K Kleinschmidt-DeMastersTimothy Vollmer
Oct 17, 2013·Journal of Neuropathology and Experimental Neurology·Christian WüthrichIgor J Koralnik
May 24, 2014·Journal of Central Nervous System Disease·Robert HoepnerAndrew Chan
Nov 1, 2016·Brain : a Journal of Neurology·Jorge CorrealeMarcela P Fiol
Oct 5, 2017·Cancer Control : Journal of the Moffitt Cancer Center·Chandrashekar BohraSamir Dalia
Jul 2, 2018·Journal of Medical Case Reports·Yinan ZhangAngela Flores
Dec 11, 2019·Degenerative Neurological and Neuromuscular Disease·Marge KartauAuli Verkkoniemi-Ahola

❮ Previous
Next ❯

Software Mentioned

ResearchGate
Google Scholar
Cochrane
Prisma

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Related Papers

The New England Journal of Medicine
Burt AdelmanMichael A Panzara
The New England Journal of Medicine
José C Alvarez-CermeñoLuisa M Villar
The New England Journal of Medicine
Thomas Berger, Florian Deisenhammer
Médecine sciences : M/S
Christian Schmitt, Armand Bensussan
© 2021 Meta ULC. All rights reserved